Tommy G Thompson is of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 8,480 shares of UTHR, which is worth approximately $3.09 Million. The most recent transaction as insider was on Nov 23, 2022, when has been sold 5,000 shares (Common Stock) at a price of $266.86 per share, resulting in proceeds of $1,334,300. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.48K
0% 3M change
0% 12M change
Total Value Held $3.09 Million

Tommy G Thompson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 23 2022
SELL
Sale (or disposition) back to the issuer
$1,334,300 $266.86 p/Share
5,000 Reduced 39.68%
7,600 Common Stock
Nov 23 2022
BUY
Exercise of conversion of derivative security
$319,500 $63.9 p/Share
5,000 Added 28.41%
12,600 Common Stock
Jul 08 2022
BUY
Exercise of conversion of derivative security
-
1,080 Added 12.44%
7,600 Common Stock
May 26 2022
SELL
Sale (or disposition) back to the issuer
$494,516 $224.78 p/Share
2,200 Reduced 25.23%
6,520 Common Stock
May 26 2022
BUY
Exercise of conversion of derivative security
$105,842 $48.11 p/Share
2,200 Added 20.15%
8,720 Common Stock
Mar 29 2022
SELL
Sale (or disposition) back to the issuer
$267,690 $178.46 p/Share
1,500 Reduced 18.7%
6,520 Common Stock
Mar 29 2022
BUY
Exercise of conversion of derivative security
$72,165 $48.11 p/Share
1,500 Added 15.76%
8,020 Common Stock
Mar 17 2022
SELL
Sale (or disposition) back to the issuer
$278,395 $184.49 p/Share
1,509 Reduced 18.79%
6,520 Common Stock
Mar 17 2022
BUY
Exercise of conversion of derivative security
$72,598 $48.11 p/Share
1,509 Added 15.82%
8,029 Common Stock
Mar 16 2022
SELL
Sale (or disposition) back to the issuer
$273,825 $182.55 p/Share
1,500 Reduced 18.7%
6,520 Common Stock
Mar 16 2022
BUY
Exercise of conversion of derivative security
$72,165 $48.11 p/Share
1,500 Added 15.76%
8,020 Common Stock
Mar 15 2022
SELL
Sale (or disposition) back to the issuer
$268,230 $178.82 p/Share
1,500 Reduced 18.7%
6,520 Common Stock
Mar 15 2022
BUY
Exercise of conversion of derivative security
$72,165 $48.11 p/Share
1,500 Added 15.76%
8,020 Common Stock
Mar 10 2022
SELL
Sale (or disposition) back to the issuer
$167,780 $167.78 p/Share
1,000 Reduced 13.3%
6,520 Common Stock
Mar 10 2022
BUY
Exercise of conversion of derivative security
$48,110 $48.11 p/Share
1,000 Added 11.74%
7,520 Common Stock
Mar 03 2022
SELL
Sale (or disposition) back to the issuer
$262,440 $174.96 p/Share
1,500 Reduced 18.7%
6,520 Common Stock
Mar 03 2022
BUY
Exercise of conversion of derivative security
$72,165 $48.11 p/Share
1,500 Added 15.76%
8,020 Common Stock
Jun 26 2021
BUY
Exercise of conversion of derivative security
-
1,680 Added 20.49%
6,520 Common Stock
Mar 10 2021
SELL
Sale (or disposition) back to the issuer
$1,972,048 $159.68 p/Share
12,350 Reduced 71.84%
4,840 Common Stock
Mar 10 2021
BUY
Exercise of conversion of derivative security
$676,410 $54.77 p/Share
12,350 Added 41.81%
17,190 Common Stock

Also insider at

VYNT
Vyant Bio, Inc. Healthcare
CNC
CENTENE CORP Healthcare
DOC
Physicians Realty Trust Real Estate
TXMD
TherapeuticsMD, Inc. Healthcare
VCKA
Vickers Vantage Corp. I Financial Services
PEAK
HEALTHPEAK PROPERTIES, INC. Real Estate
TGT

Tommy G Thompson

Rutherford, NJ

Track Institutional and Insider Activities on UTHR

Follow UNITED THERAPEUTICS Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR